Clinical Trial
Biomarker of Transdermal Vagus Nerve Stimulation
Study Description
“Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation”
The proposed project tests the hypothesis that salivary alpha amylase concentration is a reliable biomarker of the effect of transdermal vagus nerve stimulation (tVNS) in humans.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
Transdermal Vagus Nerve Stimulation
intermittent transdermal stimulation of the aurical vagus
Additional Information
Official Study Title
Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation
Clinical Trial ID
NCT03854539
ParticipAid ID
eERXma
